Latest Innovation News

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

HITIQ has secured a pivotal one-year deal with the South Metro Junior Football League, positioning its PROTEQT concussion management system at the heart of junior sports safety. This move complements existing partnerships and signals a strong push into Australia’s grassroots sports market.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

Hydralyte USA reports its best EBITDA performance since IPO, driven by strong sales and cost reductions, setting the stage for growth with upcoming product launches.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

Radiopharm Theranostics has unveiled encouraging preclinical results for its Lu177-B7H3 monoclonal antibody, RV01, paving the way for a mid-2025 Investigational New Drug submission and a Phase 1 trial later that year.

Iondrive Limited is expanding its proprietary Deep Eutectic Solvent technology into the burgeoning e-waste urban mining sector, backed by a South Australian government grant. The company aims to recover valuable metals from printed circuit boards, tapping into a global market worth billions yet largely unrecycled.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.

Atturra Limited has completed its acquisition of DalRae Solutions, a specialist SAP consultancy, aiming to deepen its footprint in SAP services across Australia and New Zealand. The deal includes upfront and performance-based payments totalling up to $20 million.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Metal Powder Works has doubled its production capacity for advanced metal powders using its patented DirectPowder™ process, achieving this milestone without additional capital expenditure. The company also cut production cycle times by up to 40%, positioning itself as a key US supplier for defence applications.

DUG Technology has secured its inaugural commercial lease for the DUG Nomad, a cutting-edge mobile immersion cooling system, marking a key milestone in its edge computing ambitions.